Trade Hikma Pharmaceuticals PLC - HIK CFD
What is Hikma (HIK)?
Hikma Pharmaceuticals is a multinational pharmaceutical company specializing in the development, manufacturing, and marketing of branded and non-branded generic medicines. Founded in 1978, the company operates across multiple regions including the Middle East, North Africa, Europe, and the United States. Hikma's product portfolio encompasses a wide range of therapeutic areas such as injectables, oral solids, and respiratory medicines. The company focuses on providing affordable and accessible healthcare solutions through its diverse product offerings. Hikma's manufacturing facilities comply with international quality standards, supporting its commitment to product safety and efficacy. The company also engages in research and development activities to enhance its pipeline and address unmet medical needs. Hikma Pharmaceuticals serves hospitals, pharmacies, and healthcare providers, contributing to the pharmaceutical supply chain in various markets. Its operational strategy includes partnerships and acquisitions aimed at expanding its global footprint and product range. Hikma is recognized for its role in the generic pharmaceutical industry and its contribution to improving patient access to essential medicines.
Hikma Stock Price Today: Live Overview
The price today is shaped by intraday trading, with Hikma currently at £12.7228. Price fluctuations have ranged from £12.5573 to £12.7771, with a daily change percentage of +1.0402%.
FAQ: Hikma (HIK)
What is the current price of HIK stock?
Hikma's last traded price is £12.7228.
Does HIK pay dividends?
Hikma pays dividends to its shareholders.
Does HIK have a formal corporate presence or regional headquarters in the UAE?
Hikma has an official office in the Dubai International Financial Centre (DIFC), UAE.
What is HIK best known for?
Hikma is most famous for its generic and branded pharmaceutical products.
What assets are typically shown together with HIK?
Commonly shown alongside HIK: The First Bancorp Inc, Leidos, iShares iBonds Dec 2030 Term Treasury ETF
Latest shares articles



